Plasma clearance of urokinase-type plasminogen activator

Fibrinolysis and Proteolysis

Volumn 12, Issue 4, 1998, Pages 251-258

  Van Der Kaaden, M E ^a   Rijken, D C ^b   Van Berkel, T J C ^a   Kuiper, J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE RECEPTOR;

BLOOD CLOT LYSIS; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLYCOSYLATION; INTERNALIZATION; LIVER METABOLISM; NONHUMAN; PLASMA CLEARANCE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ISOLATION; REVIEW;

EID: 0031735389     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80018-0     Document Type: Review

References (64)

1. Kasai S, Arimura H, Nishida M, Suyama T. Proteolytic cleavage of single-chain pro-urokinase induces a conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J Biol Chem 1985; 260: 12377-12381.
2. Wijngaards G, Rijken D C, van Wezel A L, Groeneveld E, van der Velden CAM. Characterization and fibrin-binding properties of different molecular forms of pro-urokinase form a monkey kidney cell culture. Thromb Res 1986; 42: 749-760.
3. Eaton D L, Scott R W, Baker J B. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 1984; 259: 6241-6247.
4. Dana K, Andreasen P A, Grondahl-Hansen J, Kristensen P, Nielsen L S, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-164.
5. Kentzer E J, Buko A M, Menon G, Sarin V K. Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase. Biochem Biophys Res Com 1990; 171: 401-406.
6. Buko A M, Kentzer E J, Petros A, Menon G, Zuiderweg E R P, Sarin V K. Characterization of a post-translational fucosylation in the growth factor domain of urinary plasminogen activator. Proc Natl Acad Sci USA 1991; 88: 3992-3996.
7. Steffens G J, Günzler W A, Otting F, Frankus E, Flohe L. The complete amino acid sequence of low molecular mass urokinase from human urine. Hoppe-Seyler's Physiol Chem 1982; 363: 1043-1058.
8. Bergwerff A A, Van Oostrum J, Kamerling J P, Vliegenthart J F G. The major N-linked carbohydrate chains from human urokinase. The occurrence of 4-O-sulfated, a2-6-sialylated or a 1-3-fucosylated N-acetylgalactosamineβ-4-N-acetylglucosamine elements. Eur J Biochem 1995; 228: 1009-1019.
9. Gurewich V, Pannell R, Louie S, Kelley P, Suddith R L, Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase pro-urokinase: a study in vitro and in two animal specific. J Clin Invest 1984; 73: 1731-1739.
10. Rijken D C, Binnema DJ, Los P. Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thromb Res 1986; 42: 761-768.
11. Collen D, Zamarron C, Lijnen H R, Hoylaerts M. Activation of plasminogen by prourokinase. J Biol Chem 1986; 261: 1259-1266.
12. Lijnen H R, van Hoef B, Collen D. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator. Biochim Biophys Acta 1986; 884: 402-408.
13. Liu J, Pannell R, Gurewich V, A transitional state of prourokinase that has a higher catalytic efficiency against gluplasminogen than urokinase. J Biol Chem 1992; 267: 15289-15292.
14. Pannell R, Gurewich V. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Blood 1986; 67: 1215-1223.
15. Stump D C, Lijnen H R, Collen D. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator. J Biol Chem 1986; 261: 17120-17126.
16. Collen D, de Cock F, Lijnen H R. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys. Thromb Haemost 1984; 52: 24-26.
17. Spriggs D J, Stassen J M, Hashimoto Y, Collen D. Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits. Blood 1989; 73: 1207-1212.
18. Henkin J, Dudlak D, Beebe D P, Sennello L High sialic acid content slows prourokinase turnover in rabbits. Thromb Res 1991; 63: 215-225.
19. Kuiper J, Rijken D C, de Munk CAW, van Berkel Th J C. In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells. J Biol Chem 1992; 267: 1589-1595.
20. Stoppelli M P, Corti A, Soffientini A, Cassani G, Blasi F, Assoian R K. Differentiation-enhanced binding of the aminoterminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939-4943.
21. Vassalli J D, Baccino D, Belin D. A cellular binding site for the Mr 55 000 form of the human plasminogen activator urokinase. J Cell Biol 1985; 100: 86-92.
22. Nielsen L S, Kellerman G M, Behrendt N, Picone R, Danø K, Blasi F. A 55 000-60 000 Mr receptor protein for urokinase-type plasminogen activator. J Biol Chem 1988; 263: 2358-2363.
23. Roldan A L, Cubellis M V, Massucci M T, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis. EMBO J 1990; 9: 467-474.
24. Plough M, Rønne E, Behrendt N, Jensen A L, Blasi P, Danø K. Cellular receptor for urokinase plasminogen activator. J Biol Chem 1991; 266: 1926-1933.
25. Appella E, Robinson E A, Ulrich S J, Stoppelli M P, Corti A, Cassani G, Blasi F. The receptor-binding sequence of urokinase. J Biol Chem 1987; 262: 4437-4440.
26. 2-macroglobulin receptor mediates cellular degradation of urokinase receptor bound complexes. J Biol Chem 1992; 267: 14543-14546.
27. 2-MR mediates cellular uptake of pro-urokinase. J Biol Chem 1993; 268: 21862-21867.
28. 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J Biol Chem 1993; 268: 13691-13696.
29. Stump D C, Kieckens L, de Cock F, Collen D. Pharmacokinetics of single chain forms of u-PA. J Pharm Exp Ther 1987; 242: 245-250.
30. Hiramatsu R, Kasai S, Amatsuji Y. Effect of deletion of EGF-like domain on plasma clearance of pro-urokinase. Fibrinolysis 1989; 3: 147-151.
31. Spriggs D J, Stassen J M, Hashimoto Y, Collen D. Thrombolytic properties of human t-PA, single-chain u-PA and synergistic combinations in venous thrombosis models in dogs and rabbits. Blood 1989; 73: 1207-1212.
32. Van der Kaaden M E, Rijken D C, Kruyt J K, van Berkel Th J C, Kuiper J. The role of LRP in the plasma clearance and liver uptake of recombinant single chain u-PA in rats. Thromb Haemost 1997; 77: 710-717.
33. Gurewich V, Johnstone M T, Pannell R. The selective uptake of HMW-u-PA by platelets. Fibrinolysis 1995; 9: 188-195.
34. Jiang Y, Pannell R, Liu J N, Gurewich V. Evidence for a novel binding protein to u-PA in platelet membranes. Blood 1995; 87: 2775-2781.
35. Crowley C W, Cohen R L, Lucas B K, Liu G, Shuman M A, Levinson A D. Prevention of metastasis by inhibition of the uPAR. Proc Natl Acad Sci USA 1993; 90: 5021-5025.
36. Quattrone A, Fibbi G, Anichini E, Pucci M, Zamperini A, Capapccioli S, Del Rosso M. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of uPAR gene expression. Cancer Res 1995; 55: 90-95.
37. Stahl A, Mueller B M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 1994; 54: 3066-3071.
38. Busso N, Masur S K, Lazega D, Waxman S, Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994; 126:259-270.
39. Gyetko M R, Todd R F, Wilkinson C C, Sitrin R G. The uPAR is required foir human monocyle chemotaxis in vitro. J Clin Invest 1994; 93: 1380-1387
40. Myohanen H T, Stephens R W, Hedman K, et al. Distribution and lateral mobility of the urokinase receptor complex at the cell surface. J Histochem Cytochem 1993; 41: 1291-1301.
41. Bugge T H, Sub. T T, Flick, M J, et al. The receptor for u-PA is not essential for mouse development or fertility. J Biol Chem 1995; 270: 16886-16894.
42. Estreicher A, Wohlsend A, Belin D, Vassali J D. Characterization of the cellular binding site for the u-PA. J Biol Chem 1989; 264: 1180-1187.
43. Flower B J, Mackman N, Farmer RJ, Miles L A. Single chain human urokinase binds to hamster and rat cells with high affinity: defining species speicificity of the urokinase receptor uPAR; Thromb Haemost 1997; supplement: 401.
44. 2-macroglobulin. J Cell Biol 1990; 110: 1041-1048.
45. 2-macroglobulin receptor as an approximately 440-kDa single chain protein. J Biol Chem 1989; 264: 15574-15577
46. Herz J, Hamann U, Rogne S M, Myklebost O, Gausepohl H, Stanley K K. Surface location and high affinity for calcium of a 500 kD liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 1988; 7: 4119-4127
47. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 1990; 265: 17401-17404.
48. Kowal R C, Herz J, Weisgraber K H, Mahley R W, Brown M S, Goldstein J L. Opposing effects of apolipoproteins E and C on lipoprotein binding of low density liprotein related protein. J Biol Chem 1990; 265: 10771-10779.
49. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicron remnants to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88: 8342-8346.
50. 2MR is a hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 1992; 89: 7427-7431.
51. 2-macroglobulin receptor. Proc Natl Acad Sci USA. 1992; 89: 7422-7426.
52. Herz J, Clouthier D E, Hammer R E. LDL receptor-related protein internalizes and degrades uPA-PAl-1 complexes and is essential for embryo implantation. Cell 1992; 71:411-421.
53. Kounnas M Z, Henkin J, Argraves W S, Strickland D K. LRP mediates cellular uptake of pro-urokinase. J Biol Chem 1993; 268: 21862-21867.
54. 2-macroglobulin receptor/LRP. J Biol Chem 1994; 269: 25668-25676.
55. Horn I R, van den Berg B M M, van der Meijden E, van Zonneveld A J. Recombinant fragments of the second cluster of complement-type repeats of LRP mediate the high affinity binding of different ligands as determined by surface plasmon resonance. Fibrinolysis 1996; 10: 21 (abstract 61).
56. Stefansson S, Kounnas M Z, Henkin, J, Mallampalli, R K, Chappel D A, Strickland D K, Argraves W S. Gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, PAI-1 and u-PA-PAI-1 complex. J Cell Sci 1995; 108: 2361-2368.
57. Heegaard C W, Wiborg Simonsen A C, Oka K, et al. VLDLr binds and mediates endocytosis of u-PA-PAI-1 complex. J Biol Chem 1995; 270: 20855-20861.
58. Van der Kaaden M E, Rijken D C, Groeneveld E, van Berkel Th J C, Kuiper J. Native and non-glycosylated scu-PA are recognized by different receptor systems on rat parenchymal liver cells. Thromb Haemost 1995; 74: 722-729.
59. 2MR, and the receptor associated protein RAP. J Histochem Cytochem 1994; 42: 531-542.
60. 2-macroglobulin receptor. J Biol Chem 1991; 266: 21232-21238.
61. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. J Biol Chem 1992; 267: 9035-9040.
62. Drickamer, K, Mamon J F, Binns G, Leung J O. Primary structure of the art liver ASGPr. Structural evidence for multiple polypeptide species. J Biol Chem 1984; 259: 770-778.
63. Lee Y C, Townsend R R, Hardy M R, Lonngren J, Arnarp J, Haraldsson M, lonn H. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. J Biol Chem 1983; 258: 199-202.
64. Narita M, Bu G, Olins G M, Higuchi D A, Herz J, Broze G J, Schwartz A L. Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo. J Biol Chem 1995; 270: 24800-24804.